,

Close on the heels of inking 17 MoUs , attracting over Rs 15,000 crore worth investments to the state, Tamil Nadu chief minister Edappadi K Palaniswami has directly reached out to 13 global heads of prominent companies in the electronic sector. https://www.financialexpress.com/economy/tamil-nadu-reaches-out-to-tim-cook-and-jeff-bezos-for-investments-from-apple-amazon/1975562/

0
,

NBFC body Finance Industry Development Council (FIDC) has requested approval for ‘teaser’ kind of one-time restructuring scheme for all loans without provisioning, in a meeting with finance minister Nirmala Sitharaman via video-conference on Friday.   https://www.financialexpress.com/industry/nbfc-body-seeks-teaser-kind-of-one-time-loan-restructuring-scheme/1975570/

0
,

Officials of the power ministry discussed the need to restructure the power system to make states responsible for the financial health of their power distributions companies (discoms), with the NK Singh-led FC. This would entail recalibrating state borrowing limits under the Fiscal Responsibility and Budget Management (FRBM) Act, to account for the added liabilities, theContinue reading

0
,

The three Indian companies are Alpha Design Technologies Pvt Ltd, Bharat Forge Ltd and Medha Servo Drives Pvt Ltd, the space organisation said in a statement on Friday. https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/three-indian-companies-get-licence-to-manufacture-nasas-coronavirus-ventilators/articleshow/76104447.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

0
,

SB Energy, renewable energy arm of SoftBank, has mandated Bank of America Merrill Lynch and Barclays to help raise $500-$750 million in SBG Cleantech — it’s 80:20 joint venture with Bharti, multiple people aware of the development said. https://economictimes.indiatimes.com/industry/banking/finance/softbank-bharti-jv-eyes-up-to-750-million-fund-raise/articleshow/76078064.cms

0
,

Drugmaker Sun Pharmaceutical Industries Ltd said on Friday that it received Indian regulatory approval to start clinical trials of pancreatitis drug nafamostat mesilate in COVID-19 patients.   https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-sun-pharma-to-conduct-clinical-trial-of-pancreatitis-drug-in-covid-19-patients/articleshow/76089435.cms

0